EPIDIOLEX® (cannabidiol) oral solution: Now FDA Approved, Pending Rescheduling
Click here to see Press Release.

Sign up here to receive EPIDIOLEX information and availability updates.

Contact Us

For U.S. inquiries, please fill out the form below.

For global inquiries, click here
 

Greenwich Biosciences
5750 Fleet Street, Suite 200
Carlsbad, CA 92008
Tel:  760.795.2200

Media Inquiries
Stephen Schultz
Vice President, Investor Relations
Tel: +1 917.280.2424 Direct
Email
Fax: 760.795.2219

 

Please Provide your contact information
Please specify the nature of your inquiry
Files must be less than 2 MB.
Allowed file types: txt rtf pdf doc docx.